Please login to the form below

Not currently logged in
Email:
Password:

Denmark builds world-class research centre

The Novo Nordisk Foundation has donated DKK885m to the University of Copenhagen to build a new centre for international metabolic research

The Novo Nordisk Foundation has donated DKK885m to the University of Copenhagen to build a new centre for international metabolic research.

The funds represent the largest private donation in Danish history and will enable the Novo Nordisk Foundation Centre for Basic Metabolic Research to be established at the University's Faculty of Health Sciences. It will open on October 1, 2010 and move into its new building within the next few years.

The Centre will conduct research into various so-called lifestyle diseases, including type-2 diabetes. The DKK885m (about €118m) will enable the establishment of a world-class facility where a team of five leading research scientists will work.

"This magnificent donation will transform Copenhagen into a global epicentre for metabolic research," said Ulla Wewer, dean of the Faculty of Health Sciences. "The Centre will establish a framework for leading researchers within the field. We will acquire the knowledge and facilities to make a difference to understand the basis for the development of metabolic disease, which continues to affect more and more people around the world."

Chairman of the Novo Nordisk Foundation, Dr Ulf J Johansson, stressed: "The donation of DKK885m should be seen in light of the staggering increase in the incidence of metabolic diseases. Even though these are commonly referred to as lifestyle diseases, their incidence is spread throughout the world and is not only prevalent in affluent society.

"The donation is our way of bringing the University of Copenhagen into the ranks of the international elite, in an area of research within biomedicine in which Denmark is already strong," he added.

The Novo Nordisk Foundation is an independent institution supporting scientific, humanitarian and social projects, particularly in the field of health science.

24th March 2010

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
OPEN Access Consulting

OPEN Access Consulting is a specialist market access agency within the OPEN Health Group. As value communications experts we specialise...

Latest intelligence

Is the pharma business model ready for precision medicine?
Precision medicine promises to revolutionise patient outcomes and reduce costs for industry but is pharma ready for it? Blue Latitude Health co-founder Head of Strategy Fred Bassett explores the challenges...
ABPI2018
The NHS and ABPI at 70: inching closer to the triple win
The NHS and UK pharma’s ABPI both turn 70 this year. After years of transactional relationships, there’s a will to work more closely - but friction on prices and value...
What pharma marketers can learn from behavioural science
Pharma behavioural science and traditional emotional marketing create a powerful mix of techniques that have impact on real lives....

Infographics